Non-relapse mortality in pediatric acute lymphoblastic leukemia: A systematic review and meta-analysis

Leukemia and Lymphoma

Volumn 53, Issue 5, 2012, Pages 878-885

  Blanco, Esther ^a,b   Beyene, Joseph ^a,b,c   Maloney, Anne Marie ^a   Almeida, Rowena ^a   Ethier, Marie Chantal ^a   Winick, Naomi ^d   Alexander, Sarah ^a,b   Sung, Lillian ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acute lymphoblastic leukemia; non relapse mortality; pediatrics; risk factors; treatment related mortality

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER MORTALITY; CHILDHOOD MORTALITY; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LEUKEMIA REMISSION; NON RELAPSE MORTALITY; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

CHILD; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION; RISK;

EID: 84859940348     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.639018     Document Type: Review

References (17)

1. L inabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008;112:416-432.
2. B aade PD, Youlden DR, Valery PC, et al. Trends in incidence of childhood cancer in Australia, 1983-2006. Br J Cancer 2010; 102:620-626.
3. P ui CH. Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc 2010;109:777-787.
4. L und B, Asberg A, Heyman M, et al. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer 2011;56:551-559.
5. M oricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008;111:4477-4489.
6. H argrave DR, Hann II, Richards SM, et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol 2001;112:293-299. (Pubitemid 32183469)
7. V ilmer E, Suciu S, Ferster A, et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Leukemia 2000;14: 2257-2266. (Pubitemid 32042266)
8. Conter V, Arico M, Valsecchi MG, et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995. Leukemia 2000;14:2196-2204. (Pubitemid 32042261)
9. Rubnitz JE, Lensing S, Zhou Y, et al. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer 2004;101:1677-1684. (Pubitemid 39318917)
10. S lats AM, Egeler RM, van der Does-van den Berg A, et al. Causes of death-other than progressive leukemia-in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia 2005;19:537-544. (Pubitemid 40521157)
11. Prucker C, Attarbaschi A, Peters C, et al. Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster study group. Leukemia 2009; 23:1264-1269.
12. M oghrabi A, Levy DE, Asselin B, et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 2007;109:896-904. (Pubitemid 46220632)
13. H ayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144: 427-437. (Pubitemid 46768164)
14. Bieler GS, Williams RL. Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics 1993;49:793-801. (Pubitemid 23298357)
15. S mith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:18-24. (Pubitemid 26019992)
16. L ange BJ, Smith FO, Feusner J, et al. Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. Blood 2008;111:1044-1053. (Pubitemid 351213382)
17. M oher D, Pham B, Klassen TP, et al. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol 2000;53:964-972.